John Rachoy, DPM
Podiatrist · Munster, INNPI 1124138805
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (38.7%), education and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Arthrex at 37.8% of the total. Reporting peaked in 2019 at $10,534 and has fallen 69.3% since, to $3,229 in 2025. Among podiatrist clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 270 payments — averaging $78.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$8K
- Stryker$8K
- Medwest Associates$2K
- Organogenesis Inc.$920
- Smith+Nephew$397
- Orthofix Medical, Inc.$366
- plus $2K from 24 others
What the payments were for
- Travel & lodging$5,79027%
- Food & beverage$8,18039%
- Education$6,71932%
- Gifts$4352%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 27 | $7,993 |
| Stryker(2 entities) | 89 | $7,552 |
| Medwest Associates | 6 | $1,743 |
| Organogenesis Inc. | 48 | $920 |
| Smith+Nephew | 21 | $397 |
| Orthofix Medical, Inc. | 11 | $366 |
| Kerecis Limited | 3 | $322 |
| Paratek Pharmaceuticals, Inc. | 14 | $320 |
| Lightbody Medical Technologies Inc | 6 | $305 |
| Johnson & Johnson(2 entities) | 8 | $261 |
| Treace Medical Concepts, Inc. | 5 | $183 |
| Convatec Inc. | 3 | $142 |
| Osteocentric Technologies, Inc. | 2 | $80 |
| Mimedx Group, Inc. | 3 | $70 |
| Integra Lifesciences Corporation | 2 | $58 |
| Medline Industries LP | 2 | $44 |
| Bioventus LLC | 1 | $43 |
| Averitas Pharma Inc. | 2 | $38 |
| KCI USA, Inc. | 2 | $34 |
| Hartmann USA, Inc. | 2 | $33 |
| Lifenet Health | 2 | $30 |
| Aroa Biosurgery Incorporated | 2 | $30 |
| Electronic Waveform Lab, Inc. | 1 | $29 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| ANI Pharmaceuticals, Inc. | 1 | $22 |
| Next Science LLC | 1 | $21 |
| Amgen | 1 | $19 |
| Abbott | 1 | $16 |
| Triad Life Sciences Inc. | 1 | $14 |
| Paragon 28, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUGMENT INJECTABLE$1,134
- HOFFMANN$1,128
- Kerecis Omega3 Marigen$1,067
- AXSOS$973
- VARIAX$824
- STAR$726
- GAMMA$720
- INFINITY$651
- INFINITY ADAPTIS$638
- PROstep$559
- ACTISHIELD CF$492
- INBONE$324
- Kerecis Omega3 SurgiClose$267
- Physio-Stim$238
- Viaflow$169
- SONICANCHOR$155
- NUZYRA$124
- INVISION$122
- CARTIVA$122
- PURAPLY WOUND MATRIX$108
How this compares
$21,124 in reported general payments places this provider in the 90th percentile of 131 podiatrist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 12 | $4,282 |
| Gabapentin | 127 | $1,340 |
| Etodolac | 41 | $1,044 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 74 | $863 |
| Methylprednisolone | 120 | $604 |
| Terbinafine Hcl | 77 | $562 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 65 | $533 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 21 | $424 |
| Clotrimazole | 25 | $424 |
| Pregabalin | 19 | $281 |
| Clindamycin Hcl | 18 | $236 |
| Doxycycline Hyclate | 19 | $189 |
| Ciprofloxacin Hcl | 22 | $71 |
| Tramadol Hcl | 14 | $48 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $397 | $4,28212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 131 podiatrist providers in Indiana.
Other podiatrist in Munster
- Frederick DielMunster$11K
- Jason RosenblumMunster$11K
- Michael DichosoMunster$2K
- Andrew RaderJasper$726K
- Anthony MillerIndianapolis$292K
- Corey GrohIndianapolis$57K
- Jeffrey StevensIndianapolis$56K
- James VestileTipton$44K
- Andrew KapsalisAvon$37K
- Scott HoffmanAvon$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.